Caption Management’s Aerie Pharmaceuticals AERI Stock Holding History

Caption Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-140,000	Closed	-$2.5M	–	1669
2021 Q1	$2.5M	Buy	+140,000	New	+$2.42M	0.05%	451
2020 Q2	–	Sell	-101,000	Closed	-$1.36M	–	1248
2020 Q1	$1.36M	Buy	+101,000	New	+$1.92M	0.08%	335

Other funds holding AERI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Caption Management's AERI Position: Q2 2021 in Review

Caption Management sold out of Aerie Pharmaceuticals (AERI) in Q2 2021, closing a stake of 93,808 shares — an estimated $1.68M sold.

Caption Management first reported a position in AERI in Q2 2018 and held it in 4 quarters. The position peaked at $2.63M in Q2 2018. 142 funds tracked by Wall St. Rank hold AERI as of Q2 2021.

Caption Management reported no remaining Aerie Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Caption Management sold 93,808 Aerie Pharmaceuticals shares in Q2 2021, an estimated $1.68M.
Caption Management first reported a position in Aerie Pharmaceuticals in Q2 2018 and held it in 4 quarters.
Caption Management's Aerie Pharmaceuticals position peaked at $2.63M in Q2 2018.
142 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2021.

Based on Caption Management's 13F filing for Q2 2021, filed 16 Aug 2021.